✦ LIBER ✦

Character of the invasive margin in colorectal cancer

✍ Scribed by Fabio Cianchi; Luca Messerini; Annarita Palomba; Vieri Boddi; Giuliano Perigli; Filippo Pucciani; Paolo Bechi; Camillo Cortesini

Book ID: 105446843
Publisher: Springer
Year: 1997
Tongue: English
Weight: 652 KB
Volume: 40
Category: Article
ISSN: 0012-3706
DOI: 10.1007/bf02055162

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumour budding at invasive margins and o

Tumour budding at invasive margins and outcome in colorectal cancer

✍ H. Kanazawa; H. Mitomi; Y. Nishiyama; I. Kishimoto; N. Fukui; T. Nakamura; M. Wa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

βIII-tubulin at the invasive margin of c

βIII-tubulin at the invasive margin of colorectal cancer: possible link to invasion

✍ A. Portyanko; P. Kovalev; J. Gorgun; E. Cherstvoy 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 331 KB

Predictive value of histology at the inv

Predictive value of histology at the invasive margin in the prognosis of early invasive colorectal carcinoma

✍ Tadahiko Masaki; Tetsuichiro Muto 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 394 KB

Budding invasive margin and prognosis in

Budding invasive margin and prognosis in colorectal cancer – no direct association with β-catenin expression

✍ Tuomo T. Hörkkö; Kai Klintrup; Johanna M. Mäkinen; Juha B. Näpänkangas; Hannu J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Management of early invasive colorectal

Management of early invasive colorectal cancer

✍ Ryuichi Kikuchi; Masahiro Takano; Koichi Takagi; Naoyuki Fujimoto; Ryoichi Nozak 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 787 KB

Increased epidermal growth factor recept

Increased epidermal growth factor receptor expression at the invasive margin is a negative prognostic factor in colorectal cancer

✍ Ingrid Ljuslinder; Beatrice Melin; Maria L. Henriksson; Åke Öberg; Richard Palmq 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 281 KB 👁 1 views

## Abstract The receptor tyrosine kinase epidermal growth factor receptor (EGFR) is often expressed in solid malignant tumours, and the expression has been correlated to disease progression. Multiple new agents targeted against the EGFR have been developed during the last decade, but treatment sele